The Use of Synaptic Extracellular Myo‐Inositol to Treat Developmental and Epileptic Encephalopathy

High-dose enteral myo-inositol supplementation was safely used in a patient with epileptic encephalopathy due to PLCB1 deletion, increasing CSF levels and improving seizures and brain atrophy. The hypothesized mechanism involves restoring a fetal-like state with increased membrane potential, thereby reducing neuronal firing. Based on our experience, we encourage the exploration of high-dose myo-inositol in clinical trials involving infants with severe epileptic encephalopathy.

Authors

Institutions

Publication Details

Journal
Annals of the Child Neurology Society
Published
2025-08-25
DOI
https://doi.org/10.1002/cns3.70029
Citations
1
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Use of Synaptic Extracellular Myo‐Inositol to Treat Developmental and Epileptic Encephalopathy

Susan A. Berry, Annapurna Poduri, Edward Yang, Michael J. Bennett et al.
1 citations
Annals of the Child Neurology Society
Epilepsy research and treatment
1.47
article

The Use of Synaptic Extracellular Myo‐Inositol to Treat Developmental and Epileptic Encephalopathy

Susan A. Berry, Annapurna Poduri, Edward Yang, Michael J. Bennett, Sanjay P. Prabhu, Didem Demirbas, Robin L. Haynes, E. Naomi Vos, Lance H. Rodan, Phillip L. Pearl, M. Estela Rubio‐Gozalbo, Miao He, Xiaoping Huang, Wanshu Qi, Maria K. Lehtinen, Jie Chen
article en
1 citations

Abstract

High-dose enteral myo-inositol supplementation was safely used in a patient with epileptic encephalopathy due to PLCB1 deletion, increasing CSF levels and improving seizures and brain atrophy. The hypothesized mechanism involves restoring a fetal-like state with increased membrane potential, thereby reducing neuronal firing. Based on our experience, we encourage the exploration of high-dose myo-inositol in clinical trials involving infants with severe epileptic encephalopathy.

Annals of the Child Neurology SocietyVol. 3(3)
Boston Children's Hospital (US), National Institutes of Health (US), Children's Hospital of Philadelphia (US), Harvard University (US), Maastricht University Medical Centre (NL), Maastricht University (NL), Netherlands Center for Occupational Diseases (NL), National Institute of Neurological Disorders and Stroke (US), ERN GUARD-Heart (NL), Boston Children's Museum (US), Epilepsy Foundation (AU), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US)
Diamond Blackfan Anemia Foundation, National Institutes of Health, National Institute of Neurological Disorders and Stroke
Openalex Percentile: Top 16%
Epilepsy research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.